ORYZON GENOMICS, S.A. «12345...» Page 5 out of 13 25/07/2023 14:08 ORYZON GENOMICS, S.A. Other relevant information La sociedad comunica la conversión de obligaciones convertibles Register number: 23769 24/07/2023 17:57 ORYZON GENOMICS, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del primer semestre de 2023 Register number: 23747 27/06/2023 07:47 ORYZON GENOMICS, S.A. Announcement of general shareholders’ meeting The Company communicates the resolutions approved by the Ordinary General Shareholders' Meeting Register number: 23249 24/05/2023 14:21 ORYZON GENOMICS, S.A. Total number of voting rights and capital Ampliación de capital por conversión de obligaciones Register number: 22674 24/05/2023 14:19 ORYZON GENOMICS, S.A. Total number of voting rights and capital Ampliación de capital por conversión de obligaciones Register number: 22673 22/05/2023 08:03 ORYZON GENOMICS, S.A. Announcement of general shareholders’ meeting Call of the Ordinary General Shareholders’ Meeting of Oryzon Genomics, S.A. Register number: 22618 10/05/2023 15:23 ORYZON GENOMICS, S.A. Other relevant information La sociedad remite información sobre los resultados del primer trimestre de 2023 Register number: 22504 04/05/2023 18:20 ORYZON GENOMICS, S.A. Other relevant information La sociedad comunica la conversión de obligaciones convertibles Register number: 22343 03/04/2023 07:01 ORYZON GENOMICS, S.A. Other relevant information ORYZON announces positive results from planned interim analysis of PORTICO, a Phase 2b adaptive trial in Borderline Personality Disorder Register number: 21732 28/03/2023 14:09 ORYZON GENOMICS, S.A. Total number of voting rights and capital Ampliación de capital por conversión de obligaciones Register number: 21586 Page 5 out of 13 «12345...»